Galectin-3 Inhibition With Modified Citrus Pectin in Hypertension.

ABSTRACT: We investigated the effect of galectin-3 (Gal-3) inhibition with modified citrus pectin on markers of collagen metabolism in a proof-of-concept randomized placebo-controlled trial of participants with elevated Gal-3 levels and hypertension. Although higher Gal-3 levels were associated with female sex, diabetes, and reduced glomerular filtration rate in cross-sectional analyses, treatment with modified citrus pectin did not change collagen markers. The effect of Gal-3 inhibition among individuals with heart failure warrants further investigation.

SUBMITTER: Lau ES 

PROVIDER: S-EPMC7838053 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature